Status:
COMPLETED
Diagnostic Utility of MRI in Intracerebral Hemorrhage
Lead Sponsor:
Stanford University
Conditions:
Cerebral Hemorrhage
Eligibility:
All Genders
18+ years
Brief Summary
The overall aim of this project is to prospectively determine whether MRI can improve the conventional neuroradiological evaluation (CT with or without cerebral angiography) of patients with a spontan...
Detailed Description
Spontaneous intracerebral hemorrhage (ICH) and intraventricular hemorrhage (IVH) account for at least 15% of strokes worldwide. There are many possible etiologies for spontaneous (i.e. non-traumatic) ...
Eligibility Criteria
Inclusion
- A. Men and non-pregnant women, at least 18 years of age.
- B. Patients with an ICH or IVH admitted to Stanford University Medical center within 48 hours of symptom onset.
- C. Ability to undergo MRI.
Exclusion
- A. Patients with a known (preexisting) source for ICH, for example a known untreated arterio-venous malformation.
- B. Patients receiving investigational drug therapies or procedures prior to MRI scanning.
- C. Glasgow coma scale (GCS) score \< 6 in the absence of sedating medications.
- D. Informed consent cannot be obtained either directly from the patient or from a legally authorized representative.
- E. Severe coexisting or terminal systemic disease that limits life expectancy or that may interfere with the conduct of the study
Key Trial Info
Start Date :
June 26 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 27 2010
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT00363662
Start Date
June 26 2006
End Date
January 27 2010
Last Update
November 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305